Longevity Tech Venture 'Regenesome' Exhibits at 'GATEWAY Tech TAKANAWA 2026', Showcasing Development of Nanoparticles That Reach the Brain

Regenesome Co., Ltd. (Headquarters: Minato-ku, Tokyo; President and CEO: Zentaro Sakuma; hereinafter 'Regenesome'), a longevity tech venture and group company of Space Seed Holdings Co., Ltd. (Headquarters: Minato-ku, Tokyo; Representative Director: Kengo Suzuki), exhibited at 'GATEWAY Tech TAKANAWA 2026' (commonly known as Takanawa Gateway Tech 2026 / organized by East Japan Railway Company), held on Wednesday, May 13 and Thursday, May 14, 2026, at the TAKANAWA GATEWAY Convention Center and other venues. Through research on nanoparticles, Regenesome is working to elucidate and ameliorate the root causes of aging. At this event, the company participated in three formats: a panel discussion, a booth exhibition, and an express pitch, introducing its research on longevity utilizing hypoxic environments and the development of nanoparticles that can reach the brain.

Panel Discussion: 'A Deep Dive into "LiSH" – Over 50 Demonstration Experiments Annually'

Kengo Suzuki, CEO of Regenesome, participated in a panel discussion (14:00-14:40) focusing on the No. 1 demonstration experiment 'LiSH'. This session was designed to unravel the reality and core of TAKANAWA GATEWAY CITY, where over 50 demonstration experiments are conducted annually, and the LiSH community at its heart, featuring the 'masterminds' and the startups involved in the demonstrations.

Regenesome participated as a startup that has been demonstrating its health program 'Longevity Room (hypoxic environment)' at LiSH, discussing the significance of conducting R&D and demonstrations in the Takanawa/LiSH area.

Booth Exhibition: Hypoxic Environment and Nanoparticles That Reach the Brain

Regenesome set up a booth, primarily introducing the following two initiatives:

- The potential of longevity through hypoxic environments: Introducing the possibility of achieving longevity through a health program that activates mitochondria, the cell's energy factories, using the same principle as high-altitude training.

- Development status of nanoparticles that reach the brain: Developing a unique 'disc-shaped' nanoparticle to overcome the blood-brain barrier (BBB), the biggest obstacle in delivering drugs to the brain. The company presented the current status and direction of its collaborative research with the Institute of Science Tokyo on designing particles that deliver active ingredients to the brain.

Express Pitch: 'Nanoparticles That Reach the Brain'

Regenesome participated in the 'Express Pitch', a 4-minute pitch per company for the approximately 100 exhibiting companies. In this program, each company pitched its service introduction, booth highlights, and desired partners by theme, accompanied by JR East train departure sounds. Regenesome focused on 'nanoparticles that reach the brain', presenting the potential of its longevity research and its future social significance.

Comment from Kengo Suzuki, CEO of Regenesome

'We are a company that challenges the elucidation and improvement of the root causes of aging. First and foremost, we are conducting research for people to live longer and healthier lives, centered on delivering substances to the brain, the most difficult place to reach. We value the opportunity to have introduced our challenges in longevity and the brain to many people at Takanawa/LiSH, where over 50 demonstrations are conducted annually, as a first step towards co-creation.'

About Regenesome Co., Ltd.

Regenesome aims to provide new solutions for aging suppression and regenerative medicine by utilizing nanoparticles such as exosomes. In May 2025, the company established its headquarters and research laboratory, 'Takanawa Longevity Lab', at LiSH, accelerating its business and R&D activities. Currently, it aims to establish new solutions using nanoparticles that reach the brain, contributing to the extension of healthy life expectancy and humanity's advancement into space.
https://regenesome.com/

About Space Seed Holdings Co., Ltd.

Space Seed Holdings is a space-focused deep-tech venture builder with the mission 'Make Science Fiction Non-Fiction', engaging in investment activities, research activities, and business creation. Centered on the operation of the 'Fermentation and Longevity Fund' program, which supports the social implementation of fermentation and longevity technologies, it is working to create businesses that solve social issues. It aims to assemble the technologies necessary for humanity to live in space by 2040, together with various stakeholders.
https://ss-hd.co.jp/